In addition, we found decreased serum levels of FASN in an animal disease model of NAFLD, suggesting that the serum levels of FASN could be used as one of the indicators to aid in the diagnosis of NAFLD. The gene discussed is FASN; the disease is metabolic dysfunction-associated steatotic liver disease.